Asked by: Gavin Robinson (Democratic Unionist Party - Belfast East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what recent clinical assessments his Department has made of the potential medical benefits of cannabis.
Answered by George Freeman
Cannabis and its preparations are Class B controlled drugs under the Misuse of Drugs Act 1971. Cannabis is also subject to international drug control under UN Conventions. In the United Kingdom, it is illegal to produce, possess, supply, import and export cannabis except under Home Office licence. Apart from the drug Sativex, which is derived from cannabis, the UK does not recognise herbal cannabis as having any medicinal use.
The National Institute for Health and Care Excellence (NICE) published a clinical guideline on the management of multiple sclerosis in October 2014 that does not recommend Sativex, a cannabis-derived treatment, as a cost effective use of National Health Service resources. NICE’s guideline on multiple sclerosis is published at: